— Know what they know.
Not Investment Advice

GENX OTC

Genex Pharmaceutical, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -0.0% 5Y: -99.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Specialties · Tech Score Neutral · Power 51 · $1788 mcap · 3M float · 0.0001% daily turnover

Balance Sheet Trends

Total Assets
$9M +50.5% ▲
4Y CAGR: +344.9%
Total Liabilities
$4M +132.9% ▲
4Y CAGR: +356.4%
Shareholders Equity
$5M +16.6% ▲
4Y CAGR: +336.5%
Cash & Investments
$430K +123.8% ▲
4Y CAGR: +154.6%
Total Debt
$0 +0.0% ▲
Net Debt
-$430K -123.8% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2003FY2004FY2005FY2006FY2007
— Assets —
Cash$10K$326K$296K$192K$430K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$10K$326K$296K$192K$430K
Net Receivables$877$689K$821K$173K$164K
Inventory$3K$523K$455K$460K$485K
Other Current Assets$0$1M$3M$709K$1M
Total Current Assets$16K$3M$4M$2M$2M
Property, Plant & Equip.$0$231K$177K$131K$196K
Goodwill & Intangibles$6K$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$4M$6M
Total Non-Current Assets$6K$231K$177K$4M$7M
Total Assets$22K$3M$4M$6M$9M
— Liabilities —
Accounts Payable$4K$200K$2K$5K$589K
Short-Term Debt$0$0$0$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$126K$537K$371K$276K
Total Current Liabilities$9K$326K$1M$2M$3M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$37K$0$0
Total Non-Current Liabilities$0$0$37K$45K$431K
Total Liabilities$9K$326K$1M$2M$4M
— Equity —
Common Stock$302$2K$2K$2K$2K
Retained Earnings-$91K$1M$2M$2M$3M
Accumulated OCI$0$220K$391K$210K$540K
Total Stockholders Equity$13K$3M$3M$4M$5M
Total Liabilities & Equity$22K$3M$4M$6M$9M
— Key Metrics —
Total Debt$0$0$0$0$0
Net Debt-$10K-$326K-$296K-$192K-$430K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms